Core Viewpoint - The financial performance and trading activity of Shengjian Medical indicate a mixed sentiment among investors, with notable fluctuations in financing and stockholder dynamics [1][2][3]. Group 1: Financial Performance - Shengjian Medical reported a revenue of 7.897 billion yuan for the period from January to September 2025, reflecting a year-on-year growth of 30.10% [2]. - The company's net profit attributable to shareholders reached 732 million yuan, marking a year-on-year increase of 32.36% [2]. - Cumulatively, the company has distributed 2.875 billion yuan in dividends since its A-share listing, with 1.729 billion yuan paid out in the last three years [3]. Group 2: Trading Activity - On January 28, Shengjian Medical's stock price fell by 1.41%, with a trading volume of 164 million yuan [1]. - The financing buy-in amount for the day was 16.99 million yuan, while the financing repayment was 18.75 million yuan, resulting in a net financing outflow of 1.76 million yuan [1]. - As of January 28, the total balance of margin trading for Shengjian Medical was 380 million yuan, with the financing balance accounting for 1.78% of the circulating market value, indicating a high level compared to the past year [1]. Group 3: Shareholder Dynamics - As of September 30, 2025, the number of shareholders for Shengjian Medical increased to 32,100, up by 15.06% from the previous period [2]. - The average number of circulating shares per shareholder rose to 18,048 shares, an increase of 186.92% compared to the last period [2]. - Among the top ten circulating shareholders, notable changes include a decrease in holdings by Huabao Zhongzheng Medical ETF and a slight increase by Hong Kong Central Clearing Limited [3].

Market Overview - The personal care products sector experienced a decline of 1.62% on January 28, with Yanjiang Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 4151.24, up 0.27%, while the Shenzhen Component Index closed at 14342.9, up 0.09% [1] Stock Performance - The following stocks in the personal care sector showed notable price changes: - Zhongshun Jiesang: Closed at 8.58, up 0.70% with a trading volume of 244,800 shares and a turnover of 209 million yuan [1] - Yanjiang Co., Ltd.: Closed at 16.40, down 6.23% with a trading volume of 426,300 shares and a turnover of 73 million yuan [2] - Beijia Clean: Closed at 34.18, down 3.77% with a trading volume of 31,400 shares and a turnover of 109 million yuan [2] Capital Flow - The personal care products sector saw a net outflow of 111 million yuan from institutional investors, while retail investors had a net inflow of 1.05 billion yuan [2] - The following stocks had significant capital flow: - Zhongshun Jiesang: Net inflow from institutional investors was 5.43 million yuan, with a retail net inflow of 15.08 million yuan [3] - Yanjiang Co., Ltd.: Experienced a net outflow of 1.25 million yuan from institutional investors [3] - Beijia Clean: Had a net outflow of 2.60 million yuan from institutional investors, but a net inflow of 12.19 million yuan from retail investors [3]

上市公司官网要想越做越值钱，靠的不是"多做几个页面"，而是把内容资产中心做成可持续运营的结构。案例故事、白皮书/电子书下 载、博客分类、媒体中心、培训中心，这些不是装饰，而是你长期获取信任与搜索流量的底盘。很多企业内容并不少，只是散：案例只 写"做过"，不讲场景与方案；应用页只堆图片，缺少按行业/工艺拆解的可复用模板，结果内容更新越多，结构越乱。 本文围绕集团公司内容资产沉淀与复用的真实需求，整理上海内10家服务商候选清单，并按五类服务路线归纳：综合实力领先定制型、 品牌化增长型网站定制服务商、品牌网站设计型公司、网络营销型网站服务商、性价比快速建站型服务商。更关键的是看对方能不能 把"结构"交付出来：案例页要素是否固定、下载中心权限与分层是否清晰、应用页模板能否复用、内容录入规范与字段字典是否交付。 把这些先谈清楚，后续内容才不会越做越乱，运营也才有抓手。 一、综合实力领先定制型-服务500强/集团/上市公司的高端定制头部服务商 1、华汉互联-高端网站定制｜服务 500 强、国企央企及中大型 B2B 企业的国内头部网站建设公司 综合评分：99.98（总分 100 ） ，第三方客户反馈平台综合评分，具备参考性 ...

第三届中国国际供应链促进博览会（简称 "链博会"）于 2025 年 7 月 16 日至 20 日在北京举办，作为全球首个以供应链为主题的国家级展会，此次展会首次 移师夏季，以 "链接世界、共创未来" 为主题，实现了简约、务实、精彩的圆满成功。 展会规模再创新高，吸引超过 1200 家中外企业和机构参展，线上线下观众超 21 万人次，较上届增长 5%；172 个境外团组参会，是上届的 2.2 倍。展会强 化 "链式逻辑"，通过大数据和人工智能技术升级 "找朋友" 3.0 模式，精准匹配企业与专业观众 2.4 万次，促成合作协议及意向超 6000 项，参展商首发首展 首秀 152 项新产品新技术新服务，同比增长 67%。截至展会落幕，已有 102 家企业和机构签约第四届参展，同比增长 50%。 传播方面成效显著，全网相关信息量达 26.87 万篇 / 条，较上届增长 34.8%。传播渠道实现全网覆盖，网媒与 "两微一端" 成为核心引擎，中央媒体、地方媒 体、行业媒体及境外媒体协同发力，2000 余名中外记者注册参会，境外主流媒体报道超 2.6 万篇，覆盖 110 个国家 / 地区。传播内容聚焦展会亮点、合作成 果 ...

资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状态时主动性买单形成的成交额是推 动股价上涨的力量，这部分成交额被定义为资金流入，股价处于下跌状态时主动性卖单产生的的成交额 是推动股价下跌的力量，这部分成交额被定义为资金流出。当天两者的差额即是当天两种力量相抵之后 剩下的推动股价上升的净力。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流 向。 近5日资金流向一览见下表： 该股主要指标及行业内排名如下： 证券之星消息，截至2026年1月27日收盘，稳健医疗(300888)报收于37.0元，下跌1.62%，换手率 1.03%，成交量6.0万手，成交额2.21亿元。 稳健医疗2025年三季报显示，前三季度公司主营收入78.97亿元，同比上升30.1%；归母净利润7.32亿 元，同比上升32.36%；扣非净利润6.79亿元，同比上升43.93%；其中2025年第三季度，公司单季度主营 收入26.01亿元，同比上升27.71%；单季度归母净利润2.4亿元，同比上升42.11%；单季度扣非净利润 2.18亿元，同比上升50.77%；负债率33.87%，投资收益3323.27万元，财务费用-20 ...

证券日报网讯1月27日，稳健医疗（300888）在互动平台回答投资者提问时表示，公司将严格依据《深 圳证券交易所创业板股票上市规则》等相关规定，结合公司实际情况判断并履行信息披露义务。 ...

Core Viewpoint - The company is actively addressing the market demand arising from an aging society by developing and promoting products in the fields of incontinence care and chronic wound care [2] Group 1: Product Development - The company has established a sub-brand "Light Skin Care" for adult incontinence products and is focusing on chronic wound care products such as silicone gel dressings and foam dressings [2] - Continuous product research and development, as well as market promotion, are being prioritized to meet the needs of the aging population [2] Group 2: Strategic Partnerships - The company emphasizes collaboration opportunities with civil affairs departments and elderly care institutions to align products with relevant policies and facilitate channel connections [2] Group 3: Future Plans - The company plans to steadily expand its range of elderly care products, enhance technological research and development, and rationally plan production capacity based on market conditions [2]

Market Overview - The personal care products sector experienced a decline of 1.53% on January 27, with Yanjiang Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 4139.9, up 0.18%, while the Shenzhen Component Index closed at 14329.91, up 0.09% [1] Stock Performance - Notable stock performances include: - Dengkang Oral Care (001328) closed at 40.93, up 1.99% with a trading volume of 15,900 shares and a turnover of 64.67 million yuan [1] - Beijia Clean (603059) closed at 35.52, up 0.45% with a trading volume of 22,500 shares and a turnover of 79.75 million yuan [1] - Yanjiang Co., Ltd. (300658) closed at 17.49, down 6.02% with a trading volume of 404,000 shares and a turnover of 702 million yuan [2] Capital Flow - The personal care products sector saw a net outflow of 73.09 million yuan from institutional investors, while retail investors had a net inflow of 85.19 million yuan [2] - The capital flow for individual stocks shows: - Zhongshun Jierou (002511) had a net inflow of 4.92 million yuan from retail investors, but a net outflow of 1.30 million yuan from institutional investors [3] - Other stocks like Yiyi Co., Ltd. (001206) and Jeya Co., Ltd. (301108) also experienced significant net outflows from institutional investors [3]

稳健医疗首次公开发行股票发行费用为1.56亿元，其中，承销保荐费1.23亿元。 稳健医疗2023年5月27日披露的2022年年度权益分派实施公告显示，公司以扣除回购股份后的 419,737,649股为基数，向全体股东拟每10股派发现金股利19.00元含税),每10股转增股本4股，不送红 股。 中国经济网北京1月27日讯稳健医疗（300888）(300888.SZ)今日股价下跌，截至收盘，该股报37.00元， 跌幅1.62%。该股目前处于破发状态。 稳健医疗2020年9月17日在深交所创业板上市，发行新股数量为5000万股，发行价格74.30元/股，保荐 机构为中国国际金融股份有限公司，保荐代表人为沈璐璐、王浩楠 稳健医疗首次公开发行股票募集资金总额为37.15亿元，扣除发行费用后，募集资金净额为35.59亿元。 稳健医疗最终募集资金净额较原计划多21.33亿元。稳健医疗于2020年9月11日发布的招股说明书显示， 该公司计划募集资金14.26亿元，分别用于高端敷料生产线建设项目、营销网络建设项目、研发中心建 设项目、数字化管理系统项目。 ...

Core Viewpoint - The company is actively addressing the market demand arising from an aging population by developing and promoting elderly care products, while also focusing on collaboration with relevant authorities and institutions to adapt to policy changes [1]. Group 1: Product Development and Market Strategy - The company has established a presence in the elderly care product sector, specifically in adult incontinence care under the "Light Skin Care" brand and chronic wound care with silicone gel and foam dressings [1]. - Continuous product research and market promotion efforts are being undertaken to enhance the company's offerings in the elderly care segment [1]. Group 2: Collaboration and Policy Adaptation - The company emphasizes the importance of partnerships with civil affairs departments and elderly care institutions to ensure product alignment with relevant subsidy policies [1]. - Active progress is being made in channel integration with these institutions to facilitate the distribution of elderly care products [1]. Group 3: Future Planning and Capacity - The company plans to steadily expand its elderly care product categories and strengthen technological research and development based on market demand and its own advantages [1]. - Capacity planning will be conducted in a reasonable manner according to market conditions [1].